These cellular and in vivo studies provide the first evidence that Miz1 promotes the tumorigenesis of medulloblastoma by enhancing Gli-mediated Hh signaling, thus supporting a potential oncogenic role of Miz1. Here, GLI1 is linked to medulloblastoma.